Sean Lee

Stock Analyst at HC Wainwright & Co.

(3.87)
# 576
Out of 5,182 analysts
96
Total ratings
30.85%
Success rate
18.32%
Average return
Main Sectors:

Stocks Rated by Sean Lee

Akari Therapeutics,
Apr 1, 2026
Maintains: Buy
Price Target: $1.6$27
Current: $3.83
Upside: +604.96%
Novavax
Feb 27, 2026
Maintains: Buy
Price Target: $11$16
Current: $8.12
Upside: +97.04%
Dogwood Therapeutics
Feb 20, 2026
Reiterates: Buy
Price Target: $12
Current: $1.99
Upside: +503.02%
Kazia Therapeutics
Jan 28, 2026
Reiterates: Buy
Price Target: $18
Current: $8.82
Upside: +104.08%
Plus Therapeutics
Jan 23, 2026
Maintains: Buy
Price Target: $50$25
Current: $4.80
Upside: +420.83%
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11$27
Current: $15.10
Upside: +78.81%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $10.90
Upside: +120.18%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1$0.75
Current: $0.61
Upside: +22.95%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4$19
Current: $6.68
Upside: +176.95%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5$5
Current: $0.69
Upside: +624.64%
Maintains: Buy
Price Target: $10$14
Current: $5.31
Upside: +163.65%
Reiterates: Buy
Price Target: $40
Current: $56.08
Upside: -28.67%